Therefore, whether the ECM1a/ABCG1-mediated regulation of cholesterol levels in plasma or the tumor microenvironment can directly indicate a risk for or diagnosis of ovarian cancer requires more detailed investigation. This evidence concerns the gene ABCG1 and ovarian cancer.